Abbott Labs (ABT -0.5%) reports prescriptions for its drug Niaspan fell 5% from the level six weeks ago when a study was released showing the medicine failed to prevent heart attacks. The firm told analysts on a conference call this morning the price of Niaspan was raised earlier this year, offsetting the decline in prescriptions.
Abbott Labs (ABT -0.5%) reports prescriptions for its drug Niaspan fell 5% from the level six...
Recommended For You
More Trending News
About ABT Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ABT | - | - |
Abbott Laboratories |